This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craft, J C
Right arrow Articles by Nelson, J D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craft, J C
Right arrow Articles by Nelson, J D

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 346-352

Clinicopharmacological evaluation of amoxicillin and probenecid against bacterial meningitis.

J C Craft, W E Feldman and J D Nelson

ABSTRACT

Forty-three infants and children with bacterial meningitis were treated intravenously with 200 mg of amoxicillin sodium per kg per day for 10 days. (Patients were initially treated with ampicillin and chloramphenicol until the bacterial etiology was defined.) Patients were randomly treated with amoxicillin only or with amoxicillin and four doses of probenecid (10 mg/kg per dose) orally every 6 h for 24 h before the lumbar puncture at day 10. Serum and cerebrospinal fluid (CSF) were obtained on days 1, 5, and 10 of therapy for antibiotic assay. The mean peak serum concentration of amoxicillin of 49.2 micrograms/ml was increased to 61.4 micrograms/ml in patients who received probenecid. The half-life in serum (1.5 h) and area under the curve with probenecid (112.5 micrograms/ml-h) were increased compared with those of amoxicillin alone (1.3 h and 82.2 micrograms/ml-h). The mean peak CSF concentrations on days 1 and 5 were similar, but day 1 concentrations remained between 2.0 micrograms/ml and 5.0 micrograms/ml throughout the 4 h after a dose, whereas the day 5 values decreased at the same decay rate as that in serum. All CSF concentrations were lower on day 10, but patients receiving probenecid had peak values occurring at 1 hr rather than at 0.5 h, and levels were significantly greater at 1 and 2 h after a dose. There were no deaths and patients responded well to treatment.


Antimicrob Agents Chemother. 1979 September; 16(3): 346-352




This article has been cited by other articles:

  • Willett, L. D., Dillon, H. C. Jr, Gray, B. M. (1985). Penicillin-Intermediate Pneumococci in a Children's Hospital. Arch Pediatr Adolesc Med 139: 1054-1057 [Abstract]  
  • Corrado, M. L., Gombert, M. E., Cherubin, C. E. (1982). Designing Appropriate Therapy in the Treatment of Gram-Negative Bacillary Meningitis. JAMA 248: 71-74 [Abstract]